Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Watkins

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|November 19, 2013
Managing the risk of drug-induced liver injuryP B Watkins
Journal of the American Academy of Dermatology|December 1, 1990
The role of cytochromes P-450 in cyclosporine metabolismP B Watkins
Annals of Neurology|September 1, 1984
Descending paralysis resulting from occult wound botulismS Rapoport, P B Watkins
Clinical Pharmacology and Therapeutics|November 19, 2016
Drug-induced liver injury: Advances in mechanistic understanding that will inform risk managementM Mosedale, P B Watkins
Clinical Pharmacology and Therapeutics|October 24, 2001
Erythromycin breath testL P Rivory, P B Watkins
Gastroenterology Clinics of North America|December 1, 1995
Genetic predisposition to drug-induced liver diseaseR J Fontana, P B Watkins
Hepatology (Baltimore, Md.)|August 1, 1991
Predicting drug interactions using cultured human hepatocytesK S Lown, P B Watkins
Clinical Pharmacology and Therapeutics|July 30, 2010
The application of metabonomics to predict drug-induced liver injuryT M O'Connell, P B Watkins
The New England Journal of Medicine|March 28, 1998
Hepatic dysfunction associated with troglitazoneP B Watkins, R W Whitcomb
Annals of Internal Medicine|November 15, 1990
Severe acetaminophen toxicity in a patient receiving isoniazidR Murphy, R Swartz, P B Watkins
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|November 19, 2013
Managing the risk of drug-induced liver injuryP B Watkins
Journal of the American Academy of Dermatology|December 1, 1990
The role of cytochromes P-450 in cyclosporine metabolismP B Watkins
Annals of Neurology|September 1, 1984
Descending paralysis resulting from occult wound botulismS Rapoport, P B Watkins
Clinical Pharmacology and Therapeutics|November 19, 2016
Drug-induced liver injury: Advances in mechanistic understanding that will inform risk managementM Mosedale, P B Watkins
Clinical Pharmacology and Therapeutics|October 24, 2001
Erythromycin breath testL P Rivory, P B Watkins
Gastroenterology Clinics of North America|December 1, 1995
Genetic predisposition to drug-induced liver diseaseR J Fontana, P B Watkins
Hepatology (Baltimore, Md.)|August 1, 1991
Predicting drug interactions using cultured human hepatocytesK S Lown, P B Watkins
Clinical Pharmacology and Therapeutics|July 30, 2010
The application of metabonomics to predict drug-induced liver injuryT M O'Connell, P B Watkins
The New England Journal of Medicine|March 28, 1998
Hepatic dysfunction associated with troglitazoneP B Watkins, R W Whitcomb
Annals of Internal Medicine|November 15, 1990
Severe acetaminophen toxicity in a patient receiving isoniazidR Murphy, R Swartz, P B Watkins
Pageof 10